Related Experiment Video
Updated: Jun 6, 2025

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage
Published on: January 31, 2018
EZH2 directly methylates PARP1 and regulates its activity in cancer
Qingshu Meng1,2, Jiangchuan Shen3, Yanan Ren1
1Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Abstract:
DNA repair dysregulation is a key driver of cancer development. Understanding the molecular mechanisms underlying DNA repair dysregulation in cancer cells is crucial for cancer development and therapies. Here, we report that enhancer of zeste homolog 2 (EZH2) directly methylates poly(adenosine diphosphate-ribose) polymerase-1 (PARP-1), an essential enzyme involved in DNA repair, and regulates its activity. Functionally, EZH2-catalyzed methylation represses PARP1 catalytic activity, down-regulates the recruitment of x-ray repair cross-complementing group-1 to DNA lesions and its associated DNA damage repair; on the other hand, it protects the cells from nicotinamide adenine dinucleotide overconsumption upon DNA damage formation. Meanwhile, EZH2-mediated methylation regulates PARP1 transcriptional and oncogenic activity, at least in part, through impairing PARP1-E2F1 interaction and E2F1 transcription factor activity. EZH2 and PARP1 inhibitors synergistically suppress prostate cancer growth. Collectively, our findings uncover an insight of EZH2 functions in fine-tuning PARP1 activity during DNA damage repair and cancer progression, which provides a rationale for combinational targeting EZH2 and PARP1 in cancer.
Insights
Enhancer of zeste homolog 2 (EZH2) directly modifies poly(adenosine diphosphate-ribose) polymerase-1 (PARP-1), impacting DNA repair and cancer progression. Targeting both EZH2 and PARP-1 shows promise for synergistic cancer therapy.
Area of Science:
- Molecular Biology
- Cancer Research
- Epigenetics
Background:
- DNA repair dysregulation is a critical factor in cancer development.
- Understanding molecular mechanisms of DNA repair is vital for effective cancer therapies.
Purpose of the Study:
- To investigate the role of enhancer of zeste homolog 2 (EZH2) in regulating poly(adenosine diphosphate-ribose) polymerase-1 (PARP-1) activity.
- To explore the implications of EZH2-mediated PARP-1 regulation in DNA repair and cancer progression.
Main Methods:
- Direct methylation assays to confirm EZH2's interaction with PARP-1.
- Functional studies assessing the impact of EZH2 methylation on PARP-1 activity and DNA repair.
- Analysis of EZH2-PARP-1 interaction with transcription factors like E2F1.
- In vivo studies evaluating the synergistic effects of EZH2 and PARP-1 inhibitors in prostate cancer models.
Main Results:
- EZH2 directly methylates PARP-1, repressing its catalytic activity and DNA repair functions.
- EZH2-mediated methylation impairs PARP-1's interaction with E2F1, affecting transcriptional activity.
- Combined inhibition of EZH2 and PARP-1 demonstrated synergistic suppression of prostate cancer growth.
Conclusions:
- EZH2 plays a crucial role in fine-tuning PARP-1 activity during DNA damage repair and cancer progression.
- The findings provide a molecular rationale for the combined targeting of EZH2 and PARP-1 in cancer treatment.
More Related Videos
10:26Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
06:44Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging
Published on: April 28, 2021
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules